Jane Street’s ProShares UltraShort Health Care RXD Stock Holding History

Jane Street’s Portfolio RXD Stock Details RXD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-2,880	Closed	-$259K	–	5654
2019 Q3	$259K	Buy	+2,880	New	+$254K	﹤0.01%	4333
2017 Q4	–	Sell	-1,852	Closed	-$235K	–	5103
2017 Q3	$235K	Sell	1,852 -200	-10%	-$26.3K	﹤0.01%	3969
2017 Q2	$268K	Buy	+2,052	New	+$309K	﹤0.01%	3714

Other funds holding RXD

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Jane Street's RXD Position: Q4 2019 in Review

Jane Street sold out of ProShares UltraShort Health Care (RXD) in Q4 2019, closing a stake of 2,880 shares — an estimated $259K sold.

Jane Street first reported a position in RXD in Q2 2017 and held it in 3 quarters. The position peaked at $268K in Q2 2017. 3 funds tracked by Wall St. Rank hold RXD as of Q4 2019.

Jane Street reported no remaining ProShares UltraShort Health Care position as of Q4 2019 after selling out during the quarter.
Jane Street sold 2,880 ProShares UltraShort Health Care shares in Q4 2019, an estimated $259K.
Jane Street first reported a position in ProShares UltraShort Health Care in Q2 2017 and held it in 3 quarters.
Jane Street's ProShares UltraShort Health Care position peaked at $268K in Q2 2017.
3 funds tracked by Wall St. Rank held ProShares UltraShort Health Care as of Q4 2019.

Based on Jane Street's 13F filing for Q4 2019, filed 14 Feb 2020.